Nucleix Ltd.
BioTech/Drugs - San Diego, CA, US
Nucleix Ltd. Details
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS and PCR-based epigenetics, the Company's pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Company's non-invasive EpiCheck® platform delivers highly accurate and sensitive results, all while providing a seamless testing option for patients and the healthcare system. The Company is building an EpiCheck franchise, beginning with the Bladder EpiCheck® testing kit, marketed in Europe for bladder cancer recurrence. The Company is advancing a Lung EpiCheck test toward commercialization for high-risk individuals, while advancing additional tests for high-risk diseases.
Nucleix Ltd. Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Tag Management
Google Tag Manager
Other
Mobile Friendly
Online Video Platforms
YouTube